H.C. Wainwright Emerging Ideas in Biopharma
A Monthly Discovery Series with Doug Tsao

Register for the Discovery Series

Join us for monthly discussions on emerging ideas in biopharma, featuring Doug Tsao. Mr. Tsao is a Managing Director of Equity Research at H.C. Wainwright whose research focuses on biopharmaceuticals and specialty pharmaceuticals.

Institutional
Investors

This communication is for informational purposes only. It is not intended as an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. Since H.C. Wainwright & Co., LLC is not a tax advisor, transactions requiring tax consideration should be reviewed carefully with your tax advisor. All market prices, data and other information are not guaranteed as to completeness or accuracy and are subject
to change without notice. H.C. Wainwright & Co., LLC., Member FINRA, SIPC